Long double-stranded RNA (dsRNA) can silence genes of matching sequence upon ingestion in many invertebrates and is therefore being developed as a pesticide. Such feeding RNA interference (RNAi) is best understood in the worm C. elegans, where it is thought that derivatives of ingested dsRNA, including short dsRNAs, move between cells and cause systemic silencing. Movement of short dsRNAs has been inferred using tissue-specific rescue of the long dsRNA-binding protein RDE-4 by expressing it from repetitive transgenes. We found that the use of repetitive transgenes for the tissue-specific rescue of a gene could inhibit RNAi within that tissue and could result in misexpression of the gene in other tissues. Both inhibition and misexpression were not detectable when a singlecopy transgene was used for tissue-specific rescue. In animals with single-copy rescue of RDE-4, RNAi was restricted to the tissue with RDE-4 expression. Thus, unlike previous observations using repetitive transgenes, these results suggest that binding of long dsRNA by RDE-4 in each silenced cell is required for systemic RNAi. Taken together with the requirement for long dsRNA to trigger RNAi in insects, these results suggest that the entry of long dsRNA is a necessary first step for feeding RNAi in animal cells.
INTRODUCTION
The intensity of gfp for the area after background subtraction was plotted for each worm (Supplementary Figure S2D) .
Two generations or P0 & F1 Feeding RNAi. The experiments in all Figures (except Figure 2,
Supplementary Figures S1B and C, S5A and B, and S6) were performed by feeding both the P0 and F1 generations, as described earlier (6). Control RNAi was done in parallel with all RNAi assays.
Three or four days after P0 animals were subjected to RNAi, the F1 animals were scored for gene silencing by measuring gene-specific defects (See Supplementary Table S1 
Scoring defects
For RNAi treatments, the proportions of animals that displayed the reported mutant defects upon RNAi (see Supplementary Table S1 ) were scored as "fraction silenced".
For bli-1 defects upon RNAi and upon Cas9-based genome editing, the pattern of blister formation was scored. Each animal was partitioned into eight roughly equal sections (a to h) as shown in Figure 3C with the vulva being the mid-point of the animal. Sections with >50% of their length covered by a blister were marked black and sections with <50% of their length covered in a blister or with a discontinuous blister were marked grey. Animals that did not follow the anterior more than posterior and dorsal more than ventral susceptibility pattern (a > b > c > d > e > f > g > h) were culled as variants for each genotype and the relative aggregate blister formation in each section among worms with altered susceptibility ( Figure 3D Figure S4E -H) were computed using a score of black = 1.0 and grey = 0.5 for each section of every worm. The computed values for each section in all worms of a strain were summed and normalized to the value of the highest section for that strain. To compare multiple strains, these values for each strain were multiplied by the fraction of worms that showed a blister in that strain. Using these measures of normalized relative aggregate blister formation among animals with variant susceptibility, we generated heat maps (30), where black indicates highest frequency of blisters and white indicates the lowest frequency of blisters among the sections of all strains that are being compared.
Microscopy
Animals were immobilized in 5µl of 3mM levamisole, mounted on slides, and imaged using an AZ100 microscope (Nikon) at a fixed magnification under non-saturating conditions. Images being compared on any figure were adjusted identically using Adobe Photoshop (levels adjustment) for display. Figure S2A -C). To generate merged images, the LUT was set from 0 (white) to 127 (magenta) for DsRed and from 0 (white) to 127 (green) for GFP. One channel was then overlayed on the other with 50% opacity.
ImageJ (NIH) was used to generate merged images (Supplementary

Statistical Analyses
Error bars in all cases indicate 95% confidence intervals for single proportions calculated using
Wilson's estimates with a continuity correction (Method 4 in (31)). Significance of differences between two strains or conditions was determined using pooled Wilson's estimates.
Data Availability
All strains are available upon request.
RESULTS
Expression of a repetitive transgene in a tissue can inhibit RNAi in that tissue
Until recently, studies examining the function of C. elegans genes have relied on the use of repetitive transgenes often coupled with tissue-specific promoters (e.g. 32-34) and/or RNAi (e.g. 35-37). Such an approach was also used to examine silencing by feeding RNAi. Rescue of rde-4 and rde-1 using the myo-3 promoter to drive expression in body-wall muscles from a repetitive transgene (Ex[Pmyo-
3::rde(+)]) was used to examine the systemic response to RNAi (23,24). While silencing in rde-1(-) animals with Ex[Pmyo-3::rde-1(+)] was observed only in body-wall muscles, silencing in rde-4(-)
animals with Ex[Pmyo-3::rde-4(+)] was observed in both body-wall muscles and other tissues. We found that in both cases silencing of some genes within body-wall muscle cells was substantially reduced compared to that in wild-type animals in response to feeding RNAi (compare unc-22 silencing versus unc-54 silencing in Figure 1A Figure S1D) ). Thus, rescuing rde-4 or rde-1 using tissue-specific promoters and repetitive transgenes does not reliably restore tissue-restricted silencing of all genes.
To test if these cases of reduced silencing could be explained by insufficient levels of rde expression, we overexpressed RDE-4 in the hypodermis of wild-type animals (Ex[Pnas-9::rde-4(+)]) and examined silencing. Feeding RNAi of neither bli-1 nor dpy-7 resulted in detectable silencing (Supplementary Figure S1D) . Thus, the observed lack of silencing is not because there was insufficient rde-4(+) expression but because expression of rde-4(+) within a tissue from a repetitive transgene inhibited feeding RNAi in that tissue. Such lack of silencing for both tested genes could reflect co-suppression (38) of rde-4. However, this hypothesis cannot explain the differential susceptibility of bli-1 and dpy-7 that was observed when rde-4(+) was expressed under the wrt-2 promoter. Alternatively, expression of any repetitive transgene could inhibit RNAi and the extent of inhibition could vary based on the target gene being tested and the promoter used. To test these possibilities, we expressed gfp from a repetitive transgene in the hypodermis (Ex[Pnas-9::gfp]) and examined silencing of bli-1 and of dpy-7 by feeding RNAi. Surprisingly, no silencing was detected when gfp was expressed ( Figure 1C ), suggesting that inhibition of silencing is the result of expression from a repetitive transgene and not because of rde-4 expression or co-suppression. Similar inhibition of silencing of unc-54, unc-22, and gfp was also observed in body-wall muscles when we expressed DsRed from repetitive transgenes in body-wall muscles ( Figure 1D, Supplementary Figure S2 ).
Together, our results suggest that expression from repetitive transgenes in a tissue can interfere with silencing by ingested dsRNA within that tissue.
Repetitive transgenes can produce dsRNA (39,40) that could compete with ingested dsRNA for engaging the gene silencing machinery within a cell. Such competition between pathways is the reason silencing by feeding RNAi can be enhanced in animals that lack genes required solely for the processing of endogenous dsRNA (41,42,reviewed in 43). Consistently, we found that loss of factors required for endogenous dsRNA production (the RdRP rrf-3 or the endonuclease eri-1) but not loss of Certain genes appear to be more susceptible to inhibition by expression from repetitive transgenes. For example, unc-54 was more susceptible than unc-22 ( Figure 1A ) and bli-1 was more susceptible than dpy-7 (Supplementary Figure S1A) . While the basis for these differences is unclear, we found silencing of bli-1 and unc-54 but not of unc-22 showed a dependence on the secondary Argonaute NRDE-3 (Supplementary Figure S3B) . Consistent with a role for the nuclear RNAi pathway in silencing these genes, we found that bli-1 silencing by feeding RNAi also depended on components that act downstream of NRDE-3 (46,21) (Supplementary Figure S3C) . This dependence on the nuclear RNAi pathway was also observed when bli-1 was targeted for silencing by dsRNA expressed in neurons (Supplementary Figure S3D) , suggesting that irrespective of the source of the dsRNA, NRDE-3 is required for silencing bli-1. Additional experiments are needed to establish mechanistic links, if any, between nrde-3-dependence and inhibition of RNAi by expression from repetitive transgenes.
Taken together, our analysis predicts that the use of a single-copy transgene should eliminate the inhibition observed and enable silencing by RNAi. Accordingly, using a single-copy transgene to express rde-4(+) in the hypodermis (Si[Pnas-9::rde-4(+)]) enabled potent silencing of both dpy-7 and bli-1 by feeding RNAi (Figure 1E, left) . Furthermore, this silencing could be inhibited by additionally expressing Ex (Figure 1E, right) . Thus, expression of any repetitive transgene in a tissue can inhibit silencing of some genes within that tissue and using a single-copy transgene can avoid this problem.
Rescue of rde-4 in one somatic tissue from repetitive transgenes can cause silencing within most somatic tissues but not in the germline.
When repetitive transgenes were used to rescue rde-4 in body-wall muscles, silencing upon feeding RNAi was observed in other somatic tissues (23). In contrast, when repetitive transgenes were used to rescue rde-1 in body-wall muscles, silencing was restricted to the tissue where rde-1 was expressed (47,23). These results were used to infer the intercellular movement of possibly short dsRNAs generated downstream of RDE-4 but upstream of RDE-1. To test if this observation extended to other tissues (intestine, hypodermis, and neurons), we similarly used repetitive transgenes to perform tissue-specific rescues of rde-1 and rde-4 and assessed silencing of genes expressed in somatic tissues and the germline (Figure 2A) . In all cases, silencing by feeding RNAi was observed only in one RNAi-sensitive somatic tissue when RDE-1 was expressed in that somatic tissue ( If transport of short dsRNAs, rather than misexpression, is the reason for the observed silencing, then silencing could be more common in cells that are near the source of dsRNA. However, when an animal is only scored as silenced versus not silenced in response to feeding RNAi, such qualitative differences between animals are overlooked. Examination of such differences requires a target gene whose silencing in subsets of cells can be discerned in each animal. We found that null mutants of the hypodermal gene bli-1 result in a fluid-filled sac ("blister") along the entire worm ( Figure 3A , Supplementary Figure S4A and B; (25)), and that blisters that form upon feeding RNAi in wild-type animals had a different pattern ( Figure 3B ). Specifically, anterior sections of the worm tended to be more susceptible to silencing when compared with posterior sections ( Figure 3C , Supplementary Figure S4C , and see methods), resulting in a stereotyped pattern of relative susceptibility to blister formation upon bli-1 feeding RNAi ( Figure 3C , bottom and Supplementary Figure S4D ). This bias in the tendency to form blisters likely reflects the graded uptake of dsRNA from the anterior to the posterior in the intestine upon feeding RNAi. These characteristics of blister formation as a result of bli-1 silencing enable examination of qualitative differences, if any, between silencing in wild-type animals and in animals with tissue-specific rde-4 rescue.
To systematically analyze such differences, we culled animals that had a pattern of blister formation that differed from a consensus blister susceptibility pattern observed in most wild-type animals (see methods). We found that unlike in wild-type animals, in animals with tissue-specific rescue of rde-4 from repetitive transgenes, patterns of blisters that differed from the reference pattern were common ( Figure 3D and Supplementary Figure S4E-H) . Furthermore, the pattern of variant blister susceptibility differed depending on the promoter used for tissue-specific rescue (rgef-1 or unc-119 for neurons and myo-3 or unc-54 for body-wall muscles) ( Figure 3D Figure S5) . Second, repetitive transgenes can be selectively silenced within the germline (50,51), potentially explaining the observed lack of silencing in the germline of animals with tissue-specific rde-4 rescue (Figure 2 ). Third, because repetitive transgenes could be expressed at low levels within the germline (e.g. heat shock promoter (52)), inherited RDE-4 from such expression could support feeding RNAi in all somatic tissues as was observed in rde-4(-) progeny of heterozygous parents (53). While such silencing enabled by inherited RDE-4 was not detectable in most cases, it was detectable when unc-22 silencing was examined in rde-4(-) progeny of animals with rde-4 rescued using the myo-3 promoter (Supplementary Figure S6) .
We attempted to distinguish between the movement of dsRNA between cells and the presence of RDE-4 in unintended somatic tissues upon tissue-specific rescue by restricting the presence of the dsRNA-selective importer SID-1 (9,54,55). Tissues that express high levels of SID-1 act as sinks for dsRNA (7) and the entry of both long dsRNA and short dsRNAs generated upon processing by RDE-4 are expected to require SID-1. We generated sid-1(-); rde-4(-) animals in which rde-4 was rescued using the neuronal promoter rgef-1 and sid-1 was rescued using the body-wall muscle promoter myo-3 ( Figure 4A ). In these animals, the entry of ingested dsRNA is expected to occur only into body-wall muscle cells (6-8). If expression from the rgef-1 promoter only resulted in the presence of RDE-4 in neurons, then no silencing would be detected because while long dsRNA can enter body-wall muscles through SID-1, it cannot be processed further for silencing in the absence of RDE-4. On the other hand, if expression from the rgef-1 promoter resulted in the presence of RDE-4 in neurons and in body-wall muscles, then silencing would be observed because dsRNA can both enter into and be processed in body-wall muscles. We observed silencing in these animals upon feeding RNAi of the body-wall muscle gene unc-54 ( Figure 4B ). Consistent with the restriction of SID-1-dependent dsRNA entry into body-wall muscle cells, we did not detect any silencing of the hypodermal gene bli-1. Together these results suggest that misexpression of rde-4(+) in somatic tissues when repetitive transgenes are used or the movement of RDE-4 -but not dsRNA -between cells is sufficient to explain the silencing in all somatic tissues. Therefore, we re-examined if the expression of RDE-4 in one tissue could enable silencing in other somatic tissues using single-copy transgenes. We expressed RDE-4 from a single-copy transgene using the myo-3 promoter (Si[Pmyo-3::rde-4(+)]) or the nas-9 promoter (Si[Pnas-9::rde-4(+)]) in rde-4(-) animals. In both cases, silencing was restricted to the intended tissue with RDE-4 expression ( Figure 4C ). These results do not support the possibility that RDE-4 protein or mRNA moves between cells and suggest that short dsRNAs made in one tissue are not sufficient to cause silencing in another tissue.
DISCUSSION
Our analyses in C. elegans reveal that, contrary to previous models, systemic silencing by feeding RNAi requires entry of long dsRNA into all cells that show silencing ( Figure 4D ). We provide strong evidence that the previous erroneous models resulted from the use of repetitive transgenes to study gene function. Furthermore, repetitive transgenes can inhibit feeding RNAi selectively within the tissue where the transgene is expressed.
Efficiency of RNAi could be regulated by expression from repetitive DNA
Our discovery that expression from repetitive DNA within a tissue can interfere with silencing by feeding RNAi within that tissue ( Figure 1 ) could impact studies that use RNAi to infer the function of a gene. For example, RNAi of a gene in strains that express fluorescent reporters within a tissue from a repetitive transgene could be specifically inhibited in that tissue. RNAi screens performed on strains expressing repetitive transgenes could have missed genes that are sensitive to inhibition. Thus, inferences from feeding RNAi in strains with repetitive transgenes may need to be re-examined using single-copy transgenes.
The efficiency of feeding RNAi differs between tissues and is a key concern for the application of feeding RNAi to combat animal pests (4). For example, in C. elegans, genes expressed in neurons are relatively refractory to silencing by feeding RNAi (noted in (56)). One reason for such reduced silencing could be that neurons have high levels of expression from endogenous repetitive DNA.
Consistent with this possibility, both silencing in tissues with expression from repetitive DNA (Supplementary Figure S3A) and silencing in neurons are enhanced upon loss of the exonuclease ERI-1 (57) or the RdRP RRF-3 (58). Similarly, tissue-specific expression from endogenous repetitive DNA could explain differential sensitivity to RNAi among insect tissues.
Long dsRNA is needed in every cell for silencing when an animal is subjected to feeding RNAi
The ability of dsRNA expressed in one cell to cause SID-1-dependent silencing in other cells (9,6) revealed that dsRNA or its derivatives can be exported from cells and be imported into cells in C.
elegans. The previous inference that derivatives of ingested dsRNA can also move between cells (23,24) resulted in a "transit" model for feeding RNAi where dsRNA first enters the cytosol of a cell, is subsequently processed within the cytosol of that cell, and finally exported for silencing in distant cells.
Our discovery that RDE-4 is required in each cell for silencing upon feeding RNAi (Figure 4) does not support such a transit model, and yet accounts for all silencing upon feeding RNAi. Because dsRNA can be transported across intestinal cells without entry into the cytosol (6-8) and reach the pseudocoelom that bathes all C. elegans tissues, the direct entry of dsRNA into all cells that show silencing and subsequent processing by RDE-4 in each cell is sufficient to explain the systemic response to feeding RNAi.
Taken together with recent studies, our results suggest that several characteristics of feeding RNAi in many insects and parasitic nematodes (see 59,4,60 for reviews) could be similar to those in C.
elegans. First, long dsRNA (>60 bp) is preferentially ingested (61) and realization of this preference was crucial for developing plastid expression as an effective strategy to deliver long dsRNA into crop pests (1). Second, dsRNA can be detected in intestinal cells and in internal tissues upon feeding RNAi (62). Third, with the exception of dipteran insects, most invertebrates have homologs of the dsRNA importer SID-1 (10). Finally, silencing initiated by feeding RNAi can persist for multiple generations (63). These similarities suggest that insights gleaned using the tractable animal model C.
elegans are likely to be applicable to many invertebrates, including agronomically important insect and nematode pests. 
(+)) in a rde-4(-); sid-1(-); Ex[Pmyo-3::sid-1(+)]
background no silencing is expected in muscles, which can import dsRNA (have SID-1) but not process dsRNA (lack RDE-4). Expression from an integrated array: A strain with two spontaneous integration events that generated jamIs3 and jamIs4 was designated as AMJ151 (rde-4(ne301) III; mIs11 jamIs3 jamIs4 IV).
SUPPLEMENTAL MATERIALS AND METHODS
Strains Used
jamIs3. Subsequent microinjection of a mix of Pmyo-3::rde-4 and pHC183 (as described earlier in (23)) generated jamIs4. The resultant strain was then outcrossed by mating with AMJ8 (juIs73) to generate juIs73/rde-4(ne301) heterozygotes and picking their self progeny that lack juIs73.
To express rde-4(+) in the body-wall muscle under the unc-54 promoter:
To make Punc-54::rde-4(+)::rde-4 3'UTR, the unc-54 promoter (Punc-54) was amplified with primers P22 and P24, and rde-4(+) and rde-4 3'UTR was amplified with primers P23 and P4. The two PCR products were used as templates to generate the Punc-54::rde-4(+)::rde-4 3'UTR fusion product with primers P25 and P5. To make Punc-54::gfp::unc-54 3'UTR, Punc-54 was amplified using primers P22
and P27 and gfp::unc-54 3'UTR was amplified from pPD95.75 using primers P26 and P8. The two PCR products were used as templates and Punc-54::gfp::unc-54 3'UTR fusion product was generated using the primers P25 and P13. WM49 animals were microinjected with a 1:1 mixture (10 ng/µl) of To express rde-4(+) in the hypodermis under the nas-9 promoter:
To make Pnas-9::rde-4(+)::rde-4 3'UTR, the nas-9 promoter (Pnas-9) was amplified using the primers P1 and P3, and rde-4(+) and rde-4 3'UTR was amplified using the primers P2 and P4. The two PCR To express rde-4(+) in the hypodermis under the wrt-2 promoter:
To make Pwrt-2::rde-4(+)::rde-4 3'UTR, the wrt-2 promoter (Pwrt-2) was amplified using the primers P9 and P11, and rde-4(+)::rde-4 3'UTR was amplified using the primers P10 and P4. The two PCR products were used as templates to generate the Pwrt-2::rde-4(+)::rde-4 3'UTR fusion product with primers P12 and P5. To make Pwrt-2::gfp::unc-54 3'UTR, Pwrt-2 was amplified using primers P9 and P15, and gfp::unc-54 3'UTR was amplified from pPD95.75 using primers P14 and P8. The two PCR products were used as templates to generate Pwrt-2::gfp fusion product with primers P12 and P13. To express rde-4(+) in the intestine under the sid-2 promoter:
To make Psid-2::rde-4(+)::rde-4 3'UTR, the sid-2 promoter (Psid-2) was amplified using the primers P16 and P18, and rde-4(+) along with rde-4 3'UTR was amplified using the primers P17 and P4. The two PCR products were used as templates and the Psid-2::rde-4(+)::rde-4 3'UTR fusion product was generated using the primers P19 and P5. To make Psid-2::gfp::unc-54 3'UTR, Psid-2 was amplified using the primers P16 and P21, and gfp::unc-54 3'UTR was amplified from pPD95.75 using the primers P20 and P8. The two PCR products were used as templates and the Psid-2::gfp::unc-54 3'UTR fusion product was generated using the primers P19 and P13. WM49 animals were To express rde-1(+) in the body-wall muscles under the myo-3 promoter:
As described in (23).
To express rde-1(+) in the intestine under the sid-2 promoter:
To make Psid-2::rde-1(+)::rde-1 3'UTR, the sid-2 promoter (Psid-2) was amplified using the primers P16 and P65, and rde-1(+)::rde-1 3'UTR was amplified using the primers P66 and P45. were designated as AMJ631, AMJ632, and AMJ633.
To express rde-1(+) in neurons under the rgef-1 promoter:
Made as described in (23).
To express gfp in the hypodermis under the nas-9 promoter:
To make Pnas-9::gfp::unc-54 3'UTR, the nas-9 promoter (Pnas-9) was amplified with primers P1 and P6, and gfp::unc-54 3'UTR was amplified from pPD95.75 using primers P47 and P8. The two PCR products were used as templates and Pnas-9::gfp::unc-54 3'UTR fusion product was generated using the primers P40 and P13. N2 animals were microinjected with a Pnas-9::gfp::unc-54 3'UTR in 10 mM Tris (pH 8.5) to generate transgenic lines. A representative transgenic line was designated as AMJ303.
To express DsRed in the body-wall muscle under the myo-3 promoter:
N2 animals were microinjected with pHC183 (Pmyo-3::DsRed::unc-54 3'UTR, made as described in (23)) in 10 mM Tris (pH 8.5) to generate 3 transgenic lines designated as AMJ783, AMJ784 and AMJ785.
To express sid-1(+) in the body-wall muscles under the myo-3 promoter:
As described in (6).
To express rde-4(+) in the hypodermis under the nas-9 promoter from a single-copy transgene:
EG4322 animals were microinjected with a mixture of pJM6 (22.5ng/µl) and the coinjection markers pCFJ601 (50ng/µl), pMA122 (10 ng/µl), pGH8 (10 ng/µl), pCFJ90 (2.5 ng/µl), and pCFJ104 (5 ng/µl) (plasmids described in (27)) to generate a transgenic line as described earlier (27). This isolated line was crossed into AMJ8 males and the resulting rde-4(+)/juIs73 male progeny were crossed to WM49, and homozygozed for the single-copy insertion and rde-4(-) to generate AMJ565. The integration of Pnas-9::rde-4(+)::rde-4 3'UTR in AMJ565 was verified by genotyping for the presence of Pnas-9::rde-4(+) using primers P53 and P54.
To express rde-4(+) in the body-wall muscle under the myo-3 promoter from a single-copy transgene:
EG4322 animals were microinjected with a mixture of pPR1 (22.5ng/µl) and the coinjection markers pCFJ601 (50ng/µl), pMA122 (10 ng/µl), pGH8 (10 ng/µl), pCFJ90 (2.5 ng/µl), and pCFJ104 (5 ng/µl) (plasmids described in (27)) to generate a transgenic line as described earlier (27). This isolated line was crossed into AMJ8 males and the resulting rde-4(+)/juIs73 male progeny were crossed to WM49, and homozygozed for the single-copy insertion and rde-4(-) to generate AMJ912. The integration of Pmyo-3::rde-4(+)::rde-4 3'UTR in AMJ912 was verified by genotyping for the presence of an insertion at the Mos site using primers P82-P84.
To express bli-1-dsRNA in the neurons under the rgef-1 promoter:
To make Prgef-1::bli-1-dsRNA sense strand, the rgef-1 promoter (Prgef-1) was amplified with primers P67 and P68 and a 1kb region in exon 3 of bli-1 was amplified using primers P69 and P70. The two PCR products were used as templates and Prgef-1::bli-1-dsRNA sense fusion product was generated using the primers P71 and P72. To make Prgef-1::bli-1-dsRNA antisense strand, the rgef-1 promoter (Prgef-1) was amplified with primers P67 and P73 and bli-1 was amplified using primers P74 and P75.
The two PCR products were used as templates and Prgef-1::bli-1-dsRNA antisense fusion product was generated using the primers P71 and P76. N2 animals were microinjected with a 1:1:1 ratio of without the arrays that showed silencing (fraction silenced) were determined. Also see Figure 1C .
Error bars indicate 95% confidence intervals (CI), n>22 animals and asterisks indicates p<0.01. sections (a through h, see Figure 3C ) and each section was scored for presence of a full blister (black), partial blister (grey), or no blister (white) as indicated in the inset. Scale bar = 50 µm. (D) Wildtype animals display a stereotyped pattern of susceptibility to bli-1 feeding RNAi. Progeny of wild-type animals targeted by Cas9-based genome editing, bli-1 null mutant animals, and wild-type animals exposed to feeding RNAi were scored for blister patterns as described in Figure 3C (n>45 gravid adult animals). Unlike sections in the progeny of animals that were injected with Cas9/sgRNA or in bli-1 null mutants, sections in wild-type animals that were subject to bli-1 feeding RNAi showed a stereotyped were not a > b > … > h) were plotted. Grey bounding box and n are as in (F). act-5 (blue) or bli-1 (green). Silencing was scored as in Figure 2A . Also see Figure 4C . Error bars indicate 95% CI and n>49 animals. 
SUPPLEMENTAL TABLES
